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background: Baseline anemia is associated with transfusions and increased risk of mortality in patients undergoing cardiac surgery and 
percutaneous coronary intervention. The impact of baseline anemia in patients undergoing transcatheter valve replacement (TAVR) remains unclear.
Methods: Our cohort was divided into tertiles based on hemoglobin levels. We analyzed the impact of baseline anemia and transfusion on 
mortality.
results: A total of 320 patients were included (n=114, 106, 100). Mean hemoglobin values among groups were 9.9 ± 0.7 mg/dL, 11.5 ± 0.4 
mg/dL and 13.2 ± 0.8 mg/dL. Renal insufficiency was more prevalent in the lowest tertile (70% vs. 47.5% vs. 45.3%, p<0.001). STS scores were 
significantly higher in the lowest tertile (10.5 ± 4.9 vs. 9.6 ± 4.1 vs. 8.7 ± 3.8, p=0.01). Transfusion rates were increased in the lower tertile (50% vs. 
37.7% vs. 26%, p=0.002). Death was similar at 30 days (5.3% vs. 5.7% vs. 6%, p=0.97) and at 1 year (20.2% vs. 22% vs. 17%, p=0.68). Transfusion 
was independently associated with mortality (OR 2.5, 1.4-4.3, p<0.01). Hemoglobin and hematocrit levels were not independently associated with 
mortality after both univariate and multivariate analysis.
conclusion: In patients undergoing TAVR, baseline anemia was not associated with increased mortality despite a higher prevalence of renal 
insufficiency, and a higher predicted risk based on STS scores. However, blood transfusion was associated with a significantly increased risk of 
mortality and should be avoided if feasible. 
